Moleculin Biotech (MBRX) P/E (2016 - 2026)
Moleculin Biotech (MBRX) P/E from Jun 2, 2016 to Jul 21, 2026. The TTM Moleculin Biotech (MBRX) P/E is -0.09. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Moleculin Biotech (MBRX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.09 | -14.26% |
| 2025 | -0.10 | -96.31% |
| 2024 | -2.71 | -81.22% |
| 2023 | -14.42 | +57.98% |
| 2022 | -9.13 | -54.45% |
| 2021 | -20.05 | +37.45% |
| 2020 | -14.58 | -15.55% |
| 2019 | -17.27 | +21.51% |
| 2018 | -14.21 | -43.64% |
| 2017 | -25.22 | -57.07% |
| 2016 | -58.75 | N/A |
Comparison Moleculin Biotech (MBRX) P/E with competitors
Moleculin Biotech (MBRX) P/E is -0.09.